Поиск

Автор

Ключевое слово

Коллекция

Дополнительно:

Период публикации

Научный руководитель

Оппонент

По вашему запросу найдено документов: 1662

Страница 1 из 167

PATHOPHYSIOLOGY OF CALCIUM MEDIATED VENTRICULAR ARRHYTHMIAS AND NOVEL THERAPEUTIC OPTIONS WITH FOCUS ON GENE THERAPY

Paar, V., Jirak, P., Larbig, R., Zagidullin, N.S., Brandt, M.C., Lichtenauer, M., Hoppe, U.C., Motloch, L.J. (2019)

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia

Motloch, LJ;, Jirak, P;, Gareeva, D;, Davtyan, P;, Gumerov, R;, Lakman, I;, Tataurov, A;, Zulkarneev, R;, Kabirov, I;, Cai, BZ;, Valeev, B;, Pavlov, V;, Kopp, K;, Hoppe, UC;, Lichtenauer, M;, Fiedler, L;, Pistulli, R;, Zagidullin, N (2022)

.081, CI 95% 1.035;1.129, p = 0.017), but not ST2 or hs-TnI. In contrast, during one-year FU post hospital

Investigation of hs-TnI and sST-2 as Potential Predictors of Long-Term Cardiovascular Risk in Patients with Survived Hospitalization for COVID-19 Pneumonia

Fiedler, L., Motloch, L.J., Jirak, P., Gumerov, R., Davtyan, P., Gareeva, D., Lakman, I., Tataurov, A., Lasinova, G., Pavlov, V., Hauptmann, L., Kopp, K., Hoppe, U.C., Lichtenauer, M., Pistulli, R., Dieplinger, A.-M., Zagidullin, N. (2022)

proportional-hazards analysis: besides age (HR = 1.047, 95% CI = 1.012–1.084, p = 0.009), hs-TnI (HR = 4

COMBINING NOVEL BIOMARKERS FOR RISK STRATIFICATION OF TWO-YEAR CARDIOVASCULAR MORTALITY IN PATIENTS WITH ST-ELEVATION MYOCARDIAL INFARCTION

ZAGIDULLIN, N.SH., MOTLOCH, LUKAS J,, GAREEVA, D.F., HAMITOVA, AYSILU, LAKMAN, I.A., KRIONI, ILJA, POPOV, DENIS, ZULKARNEEV, R.KH., PAAR, VERA, KOPP, KRISTEN, JIRAK, PETER, ISHMETOV, V.SH., HOPPE, UTA C., TULBAEV, EDUARD, V.N. Pavlov (2020)

for cardiovascular mortality (CV-mortality). NT-proBNP (HR = 1.64, 95% CI = 1.21–2.21, p = 0.001) but also ST2 (HR

Effects of Angiotensin Receptor-Neprilysin Inhibitors (ARNIs) on the Glucose and Fat Metabolism Biomarkers Leptin and Fructosamine

Bernhard, Ohnewein, Zornitsa, Shomanova, Vera, Paar, Albert, Topf, Peter, Jirak, Lukas, Fiedler, Christina, Granitz, Vincent, Van Almsick, Dilvin, Semo, Naufal, Zagidullin, Anna-Maria, Dieplinger, Juergen, Sindermann, Holger, Reinecke, Uta, C Hoppe, Rudin, Pistulli, Lukas, J Motloch (2023)

significantly (LVEF: 30.2 ± 7.8% to 37.6 ± 10.0%, (p < 0.001) and a significant improvement of the mean NYHA

Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors

Motloch, L.J., Jirak, Peter, Mirna, Moritz, Fiedler, Lukas, Davtyan, P.A., Lakman, I.A., Gareeva, D.F., Tyurin, A.V., Gumerov, R.M., Matskeplishvili, S.T., Pavlov, V.N., Cai, Benzhi, Kopp, Kristena, Topf, Alberta, Hoppe, Uta C., Pistulli, Rudini, Zagidullin, N.S. (2022)

-cause mortality. All-cause mortality (CVM) was attenuated by prophylactic DOAC (0.6%, P < 0.001) and dipyridamole

Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors

.5/64.9) years, p = n.s.; male: 41.5% vs 43.7%, p = n.s.) and in the history of relevant CV-disease were observed

Реорганизация рентгенологических исследований молочных желез для раннего выявления онкологической патологии в условиях пандемии COVID-19

Overhaul of Radiological Mammography Check-ups for Early Malignancy Diagnosis during COVID-19 Pandemic

М. С. Ермакова, M. S. Ermakova, С. М. Демидов, S. M. Demidov, Д. А. Демидов, D. A. Demidov (Креативная хирургия и онкология, №4, 2021)

Восстановление анатомического соотношения элементов анального канала путем пластики связки Паркса при геморрое IV стадии

Anatomical Arrangement Reconstruction of Anal Canal Parts via Plasty of the Ligament of Parks in Stage IV Hemorrhoids

А. А. Карташев, A. A. Kartashev, А. Л. Чарышкин, A. L. Charyshkin (Креативная хирургия и онкология, №1, 2024)

Симптоматическая терапия на фоне коррекции белково-энергетической недостаточности у больных генерализованными формами рака желудочно-кишечного тракта

Supportive care against correcting protein-energy malnutrition in patients with generalized gastrointestinal cancer

О. М. Петрова, O. M. Petrova, О. Н. Липатов, O. N. Lipatov, Л. Н. Кудряшова, L. N. Kudryashova (Креативная хирургия и онкология, №4, 2022)

Страница 1 из 167